Stylistic Word Choice in the Holy Quran “Its Semantic Dimensions and Argumentative Potential”
Journal of Arts and Social Sciences · 30.04.2026 · 17 (2) · 15-22
DOI: 10.53542/2522-2279.1466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Arts and Social Sciences, online erschienen am 30.04.2026. Verfasst von Abdel Hakim Ahmed Sir Al-Khatim Jini. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
This research aims to study the stylistic choice of words and trace their semantic and argumentative movement by shedding light on the precision of the stylistic choice of Quranic words, which carry argumentative potential and persuasive semantic dimensions through their context. The recipient has no choice but to submit and acquiesce. The study examines these words in terms of their lexical and semantic content, not as a departure from the linguistic norm. The study examines examples from the Holy Quran, where the word is evaluative, lively, and charged with semantic dimensions and persuasive argumentative potential. These words compel the recipient to submit and acquiesce to what is presented to them. They possess semantic features that connect them to the context in which they appear, directing them in an influential argumentative direction.
Zitieren
APA
Jini, A. H. A. S. A. (2026). Stylistic Word Choice in the Holy Quran “Its Semantic Dimensions and Argumentative Potential”. Journal of Arts and Social Sciences, 17(2), 15-22. https://doi.org/10.53542/2522-2279.1466
Vancouver
Jini AHASA. Stylistic Word Choice in the Holy Quran “Its Semantic Dimensions and Argumentative Potential”. Journal of Arts and Social Sciences. 2026;17(2):15-22. doi:10.53542/2522-2279.1466
BibTeX
@article{Jini2026,
author = {Jini, Abdel Hakim Ahmed Sir Al-Khatim},
title = {Stylistic Word Choice in the Holy Quran “Its Semantic Dimensions and Argumentative Potential”},
journal = {Journal of Arts and Social Sciences},
year = {2026},
volume = {17},
number = {2},
pages = {15--22},
doi = {10.53542/2522-2279.1466}
}
EUVIMED